Q2 FY2026 EarningsQ2 FY26 results beat consensus on both top and bottom lines: revenue $570.3M vs. $559.6M expected, and adjusted EPS $1.76 vs. $1.28. Despite the beat, management reduced the full-year pro forma constant currency revenue growth guidance to 3.5%-4.5% due to integration delays in the acquired Biotronik business. However, adjusted EPS guidance was raised to $6.90-$7.20, reflecting aggressive capital allocation including $250M in share repurchases and $700M in debt reduction.
Overview: Teleflex(TFX) the Revenue is 570.33 M (-26.96%), Beat estimate;the EBIT is 111.79 M (-46.78%), Beat estimate;the EPS is 2.28 (-17.69%), Beat estimate.